FDA removes ‘black box’ warning label on hormone replacement therapy for menopause
Lead On Monday the U.S. Food and Drug Administration announced it will remove the agency’s highest-risk “black box” warning from hormone replacement therapy (HRT) products used for menopause, reversing guidance put in place after two early-2000s studies. The decision follows a months-long expert-panel review of recent evidence and public testimony and is intended to address … Read more